Arbutus Biopharma Corp Public Float
Arbutus Biopharma Corp (ABUS) had Public Float of $472.13 million as of 2025-06-30, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-23
- 2025-06-30: Entity Public Float $472.13M.
- 2024-06-30: Entity Public Float $454.40M.
- 2023-06-30: Entity Public Float $288.13M.
- 2022-06-30: Entity Public Float $290.42M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $472.13M 10-K · filed 2026-03-23 |
| 2024-06-30 | $454.40M 10-K · filed 2025-03-27 |
| 2023-06-30 | $288.13M 10-K · filed 2024-03-05 |
| 2022-06-30 | $290.42M 10-K · filed 2023-03-02 |
| 2021-06-30 | $238.48M 10-K · filed 2022-03-03 |
| 2020-06-30 | $129.69M 10-K · filed 2021-03-04 |
| 2019-06-30 | $118.25M 10-K · filed 2020-03-05 |
| 2018-06-30 | $269.74M 10-K · filed 2019-03-07 |
| 2017-06-30 | $198.19M 10-K · filed 2018-03-16 |
| 2016-06-30 | $190.69M 10-K · filed 2017-03-22 |
| 2015-06-30 | $644.04M 10-K · filed 2016-03-09 |
| 2014-06-30 | $288.36M 10-K · filed 2015-03-13 |
| 2013-06-30 | $67.79M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |